微小RNA-4491在胃癌血清中的表达及其临床意义  被引量:4

Expression of serum microRNA-4491 in gastric cancer and its clinical significance

在线阅读下载全文

作  者:郭红艳[1] 徐亚茹 李耕慧[3] 孙晓杰[1] 赵正林 吴琦[1] 刘波 黄声凯 黄常志 宋悦 GUO Hong-yan;XüYa-ru;LI Geng-hui;SUN Xiao-jie;ZHAO Zheng-lin;WU Qi;LIU Bo;HUANG Sheng-kai;HUANG Chang-zhi;SONG Yue(Department of Medical Technology,Qiqihar Medical University,Qiqihar 161006,Heilongjiang Province,China;Department of Laboratory Medicine,the First Affiliated Hospital of Qiqihar Medical University,Qiqihar 161042,Heilongjiang Province,China;Cadre Ward of Qiqihar First Hospital,Qiqihar 161000,Heilongjiang Province,China;Department of Respiratory and Critical Care Medicine,Third Affiliated Hospital of Qiqihar Medical College,Qiqihar 161006,Heilongjiang Province,China;Department of Clinical Laboratory,National Cancer Center/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China;Department of Etiology and Carcinogenesis,Skate Key Laboratory of Molecular Oncology,Beijing Key Laboratory for Carcinogenesis and Cancer Prevention,National Cancer Center/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China)

机构地区:[1]齐齐哈尔医学院医学技术学院,齐齐哈尔161006 [2]齐齐哈尔医学院附属第一医院检验科,黑龙江齐齐哈尔161042 [3]齐齐哈尔市第一医院老年科,黑龙江齐齐哈尔161042 [4]齐齐哈尔医学院附属第三医院呼吸与危重症医学科,黑龙江齐齐哈尔161006 [5]国家癌症中心/国家肿瘤临床研究中心/中国医学科学院北京协和医学院肿瘤医院检验科,北京100021 [6]国家癌症中心/国家肿瘤临床研究中心/中国医学科学院北京协和医学院肿瘤医院病因室分子肿瘤学国家重点实验室癌发生及预防北京市重点实验室,北京100021

出  处:《中国临床药理学杂志》2022年第10期1034-1037,共4页The Chinese Journal of Clinical Pharmacology

基  金:黑龙江省省属高等学校基本科研业务费科研基金资助项目(2019-KYYWF-1219)。

摘  要:目的检测微小RNA-4491(miR-4491)在胃癌患者血清中的表达水平,分析其与胃癌临床病理特征的相关性,探讨其单独检测及其与CA72-4联合检测在胃癌诊断中的临床价值。方法实时荧光定量聚合酶链反应检测胃癌患者和健康受试者血清中miR-4491的表达水平,通过受试者工作特征(ROC)曲线、曲线下面积(AUC)、危险分数分析法评估miR-4491对胃癌的诊断效能,计算灵敏度、特异度、阳性预测值(PPV)和阴性预测值(NPV),探讨miR-4491独立及与CA72-4联合检测在胃癌诊断中的应用价值。结果胃癌组和健康对照组血清miR-4491的相对表达水平分别为3.65±4.04和1.29±1.21,二者比较,差异有统计学意义(P<0.01),miR-4491的表达量与胃癌临床分期、淋巴结及远处转移均不相关(P>0.05),但与其病理分化程度呈负相关(P<0.05)。miR-4491独立检测诊断胃癌的AUC为0.78,敏感度、特异度、PPV、NPV分别为84.5%,59.4%,74.0%和72.9%,而CA72-4诊断胃癌的AUC为0.71,敏感度、特异度、PPV和NPV分别为20.9%,78.3%,51.9%和47.0%。MiR-4491与CA72-4联合诊断的AUC为0.83,PPV和NPV分别提高至87.1%和89.7%。结论miR-4491在胃癌血清中高表达,是胃癌临床筛查的潜在血清学标志物。Objective To detect the expression level of microRNA-4491(miR-4491)in the serum of patients with gastric cancer,analyze its correlation with the clinicopathological features of gastric cancer,and explore the clinical value of its single and combined detection with CA72-4 in the diagnosis of gastric cancer.Methods The expression of serum mir-4491 in patients with gastric cancer and healthy subjects was detected by real-time fluorescence quantitative pllymerae chain reaction.The diagnostic efficacy of miR-4491 for gastric cancer was evaluated by receiver operating characteristic(ROC)curve,area under curve(AUC)and risk score analysis.To explore the application value of miR-4491 independent and combined with CA72-4 in the diagnosis of gastric cancer by calculating sensitivity,specificity,positive predictive value(PPV)and negative predictive value(NPV).Results The relative expression levels of serum miR-4491 in gastric cancer group and healthy control group were 3.65±4.04 and 1.29±1.21 and the difference was statistically significant(P<0.01).The expression of miR-4491 was not correlated with clinical stage,lymph nodes and distant metastasis of gastric cancer(P>0.05),but negatively correlated with the degree of pathological differentiation(P<0.05).The AUC of miR-4491 in the diagnosis of gastric cancer was 0.78,and the sensitivity,specificity,PPV and NPV were 84.5%,59.4%,74.0%and 72.9%respectively,while the AUC of CA72-4 in the diagnosis of gastric cancer was 0.71,and the sensitivity,specificity,PPV and NPV were 20.9%,78.3%,51.9%and 47.0%respectively.The AUC of miR-4491 combined with CA72-4 was 0.83,and the PPV and NPV were raised to 87.1%and 89.7%,respectively.Conclusion MiR-4491 is highly expressed in the serum of gastric cancer and is a potential serological marker for clinical screening of gastric cancer.

关 键 词:胃癌 非编码RNA 微小RNA-4491 血清标志物 

分 类 号:R97[医药卫生—药品]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象